---
title: "Tenax Therapeutics, Inc. (TENX.US)"
type: "quote"
locale: "en"
url: "https://longbridge.com/en/quote/TENX.US.md"
symbol: "TENX.US"
name: "Tenax Therapeutics, Inc."
industry: "生物技术"
---

# Tenax Therapeutics, Inc. (TENX.US)

| Item | Detail |
|------|--------|
| Industry | 生物技术 |
| Location | 美股市场 |
| Website | [www.tenaxthera.com](https://www.tenaxthera.com) |

## Company Profile

Tenax Therapeutics, Inc.是一家临床阶段的制药公司，在美国开发新型心肺治疗方法。它开发的 TNX-101、TNX-102 和 TNX-103（左西孟旦）已完成针对心力衰竭伴有保留射血分数和相关肺动脉高压患者的 II 期临床试验；以及 TNX-201（伊马替尼），一种用于治疗慢性髓性白血病的酪氨酸激酶抑制剂。该公司曾名为 Oxygen Biotherapeutics, Inc.，并更名为 Tenax Therapeutics, Inc

## Valuation Analysis

| Metric | Current | Industry Ranking | High | Median | Low |
|--------|---------|-----------------|------|--------|-----|
| PE (TTM) | -1.77 | 247/604 | - | - | - |
| PB | 0.80 | 70/604 | 2.44 | 2.13 | 0.79 |
| Dividend Yield | 0.00% | - | - | - | - |

## Institutional View

### Analyst Rating Distribution

> As of 2025-12-18T05:00:00.000Z

Total Analysts: **5**

| Rating | Count | Percentage |
|--------|-------|-----------|
| Buy | 4 | 80% |
| Overweight | 1 | 20% |
| Hold | 0 | 0% |
| Underweight | 0 | 0% |
| Sell | 0 | 0% |

### Target Price Forecast

| Metric | Price |
|--------|-------|
| Current Price | 12.26 |
| Highest Target | 30.00 |
| Lowest Target | 13.52 |

## References

- [Company Overview](https://longbridge.com/en/quote/TENX.US/overview.md) - Shareholders, executives, business segments
- [Financials](https://longbridge.com/en/quote/TENX.US/norm.md) - Income statement, balance sheet, cash flow, distribution plan
- [Topics & Discussions](https://longbridge.com/en/quote/TENX.US/topics.md) - Community topics and discussions

---

> **Disclaimer**: This article is for reference only and does not constitute any investment advice.